Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Clascoterone safely promotes hair growth similar to minoxidil.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

New treatments for hair loss are being developed using molecular biology.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

The hCG diet and testosterone therapy can cause hair loss in some people.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The painting of an 18th-century Sicilian baroness shows she had hair loss, possibly due to ovarian issues, insulin resistance, or a specific type of tumor.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

New oral treatment, finasteride, effectively and safely treats common hair loss.

The mouse models are effective for testing new hair loss treatments.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Spironolactone may cause increased brain pressure in some patients.

Epigenetic changes might protect occipital hair from male pattern baldness.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

Androgenetic alopecia is a condition causing noticeable hair loss, especially in middle age, which is more severe than normal balding.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.